Clinical Chemistry and Laboratory Medicine (CCLM) · 2020 · 68 citations · 11 references
Life SciencesBiochemistryImmunologyClinical ImmunologyMolecular DiagnosticsMonoclonal AntibodiesAntibody CharacterizationDiagnostic ImmunologyEnzyme-linked Immunosorbent AssayProtein CharacterizationProtein ElectrophoresisProtein SeparationAccuracyImmunoassay MethodologyImmunofixation ElectrophoresisM-protein DetectionMonoclonal Antibody AssaysMonoclonal Gammopathy DetectionMonoclonal ProteinSerum Protein Electrophoresis
Background Serum protein electrophoresis (SPEP) is used to quantify the serum monoclonal component or M-protein, for diagnosis and monitoring of monoclonal gammopathies. Significant imprecision and inaccuracy pose challenges in reporting small M-proteins. Using therapeutic monoclonal antibody-spiked sera and a pooled beta-migrating M-protein, we aimed to assess SPEP limitations and variability across 16 laboratories in three continents. Methods Sera with normal, hypo- or hypergammaglobulinemia were spiked with daratumumab, Dara (cathodal migrating), or elotuzumab, Elo (central-gamma migrating), with concentrations from 0.125 to 10 g/L (n = 62) along with a beta-migrating sample (n = 9). Provided with total protein (reverse biuret, Siemens), laboratories blindly analyzed samples according to their SPEP and immunofixation (IFE) or immunosubtraction (ISUB) standard operating procedures. Sixteen laboratories reported the perpendicular drop (PD) method of gating the M-protein, while 10 used tangent skimming (TS). A mean percent recovery range of 80%-120% was set as acceptable. The inter-laboratory %CV was calculated. Results Gamma globulin background, migration pattern and concentration all affect the precision and accuracy of quantifying M-proteins by SPEP. As the background increases, imprecision increases and accuracy decreases leading to overestimation of M-protein quantitation especially evident in hypergamma samples, and more prominent with PD. Cathodal migrating M-proteins were associated with less imprecision and higher accuracy compared to central-gamma migrating M-proteins, which is attributed to the increased gamma background contribution in M-proteins migrating in the middle of the gamma fraction. There is greater imprecision and loss of accuracy at lower M-protein concentrations. Conclusions This study suggests that quantifying exceedingly low concentrations of M-proteins, although possible, may not yield adequate accuracy and precision between laboratories.
11
Review of 1027 Patients With Newly Diagnosed Multiple Myeloma
Robert A. Kyle, Morie A. Gertz, Thomas E. Witzig et al. · Mayo Clinic Proceedings · 2003 · 2.4K citations
Medicine, Hematology, Oncology +10
Screening Panels for Detection of Monoclonal Gammopathies
Jerry A. Katzmann, Robert A. Kyle, Joanne Benson et al. · Clinical Chemistry · 2009 · 340 citations · Full text
Medicine, Hematology, Pathology +15